Advice
following an abbreviated submission:
insulin lispro (Humalog® KwikPen) is accepted for use within NHS Scotland for the treatment of adults and children with diabetes mellitus who require insulin for maintenance of normal glucose homeostasis, and for the initial stabilisation of diabetes mellitus.
It may be used in patients for whom treatment with this short-acting insulin analogue is appropriate.
Download detailed advice29KB (PDF)
Medicine details
- Medicine name:
- insulin lispro (Humalog KwikPen)
- SMC ID:
- 508/08
- Indication:
- for adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
- Pharmaceutical company
- MSD
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 13 October 2008